AB
PLRX icon

Amalgamated Bank’s Pliant Therapeutics PLRX Stock Holding History

Amalgamated Bank’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,905
Closed -$3K – 3107
2025
Q1 		$3K Hold
1,905
– – ﹤0.01% 2799
2024
Q4 		$25K Hold
1,905
– – ﹤0.01% 2037
2024
Q3 		$21K Hold
1,905
– – ﹤0.01% 2118
2024
Q2 		$20K Hold
1,905
– – ﹤0.01% 2119
2024
Q1 		$28K Sell
1,905
-6,094
-76% -$101K ﹤0.01% 2019
2023
Q4 		$145K Sell
7,999
-567
-7% -$8.62K ﹤0.01% 1891
2023
Q3 		$149K Hold
8,566
– – ﹤0.01% 1877
2023
Q2 		$155K Buy
+8,566
New +$203K ﹤0.01% 1915
2022
Q2 		– Sell
-3,844
Closed -$27K – 3160
2022
Q1 		$27K Buy
+3,844
New +$39.2K ﹤0.01% 2710

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Amalgamated Bank's PLRX Position: Q2 2025 in Review

Amalgamated Bank sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 1,905 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in PLRX in Q1 2022 and held it in 9 quarters. The position peaked at $155K in Q2 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Amalgamated Bank reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,905 Pliant Therapeutics shares in Q2 2025, an estimated $3K.
  • Amalgamated Bank first reported a position in Pliant Therapeutics in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Pliant Therapeutics position peaked at $155K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.